ArticleCancer immunology, immunotherapy : CII2025

Combined CHK1 and PD-L1 blockade as a novel therapeutic strategy against stemness and immunosuppression in ovarian cancer.

Mengqing Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.